retatrutide parkinson disease clinical trial Parkinson's drug therapies in the pipeline: 2015–2024 Unapproved weight loss drug retatrutide

G-Protein-Coupled estrogen receptor (GPER) and sex-specific metabolic homeostasis

Convient aux vgtaliens et aux vgtariens

doi: 10.1016/j.cell.2023.08.005 98 GendronT

95,96 This tissue destruction is one of the important features of COPD

The choice between injection and pill depends on which medicine is prescribed, personal preference, and overall health needs

In addition to intrinsic and idiosyncratic DILI, medications can also cause liver injury through various patterns, including steatohepatitis and neoplastic (anabolic steroid-induced or nodular regenerative hyperplasia) and vasculitis (azathioprine-induced hepatic sinusoidal obstruction syndrome) ( Fig